000 06486cam a2200409Ii 4500
001 96545
003 ES-MaUEC
005 20230102112759.0
006 m o d
007 cr |n|||||||||
008 170927s2017 sz o 000 0 eng d
020 _a3319645501
_q(electronic bk.)
020 _a9783319645506
_q(electronic bk.)
020 _z331964548X
020 _z9783319645483
040 _aYDX
_beng
_cYDX
_dN$T
_dEBLCP
_dGW5XE
_dN$T
_dNJR
_dAZU
_dUPM
_dMERER
_dOCLCF
_dIOG
_dCOO
_dOCLCQ
_dES-MaUEC
_bspa
050 4 _aRC268.4
_b2017 EB
245 0 0 _aCancer genetics and psychotherapy
_cParvin Mehdipour, editor.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
500 _a
_bSpringer Biomedical and Life Sciences eBooks 2017 English+International
505 0 _aPreface; Philosophical Flavors; Scientific Insights of This Book; This Book Presents 26 Chapters with the Following Contents in Brief; Contents; An Introduction to Pave the Ways; Basic Principles of Medical Ethics; The Relationship Between Medicine and Ethics; Health and Illness; The Physician-Patient Relationship; The Rights of Patients; Therapy and Research; Individualism and Cross-cultural Bioethics; Biopolitics, BioLaw, Bioethics; Summary; References; 1 Psycho-oncology: The Relationship Between Psychology, Personality and Cancer; Abstract; 1.1 Introduction
505 8 _a1.2 How Does Cancer Affect People Psychologically?1.3 Cancer and Culture; 1.4 Cancer and Personality; 1.5 Cancer-Prone Personality Types; 1.6 Cancer-Resistant Personality Type?; 1.7 Cancer and the Concept of 'Suffering'; 1.8 A Note on Psychotherapy; 1.9 Conclusions; References; 2 Psychotherapy in Cancer; Abstract; 2.1 Introduction; 2.2 Choice of Therapy; 2.3 Complementary and Alternative Medicine; 2.4 Differences in the Consultation Between CAM and Orthodox Medicine; 2.5 Conclusion; References; 3 New Developments in Psycho-oncology; Abstract; 3.1 Psycho-oncology: From Past to Present
505 8 _a3.2 Psycho-oncology: Some General Approaches3.3 Breaking Bad News: Informing Patients About Cancer Diagnosis; 3.4 Coping with Cancer-Associated Stress, Pain and Fatigue; 3.5 Managing Side Effects of Cancer Treatments: A Psychological Approach; 3.6 Fear of Recurrence; 3.7 End of Life Decisions and Palliative Care; 3.8 Conclusions; 3.9 Summary; References; 4 Psychiatric and Psychosocial Aspects of Breast Cancer Diagnoses and Treatments; Abstract; 4.1 Introduction; 4.2 Epidemiology of Breast Cancer; 4.3 Psychiatric Disorders in Cancer Patients
505 8 _a4.3.1 Pathophysiology of Depression in Cancer Patients, How Important to Treat?4.3.2 Psychiatric Disorders in Cancer Patients, Dianosis and Treatments; 4.3.3 Depression in Advanced Cancer and Palliative Care; 4.3.4 Psychosocial Aspects of Breast Cancer; 4.3.5 Sleep Problems in Patients with Breast Cancer; 4.3.6 Hormonal Therapy and Chemotherapy in Breast Cancer; 4.3.7 The Effect of Hormonal Therapy or Chemotherapy on Mood; 4.3.8 Pharmacological Treatments of Psychiatric Symptoms in Patients with Breast Cancer; 4.4 Psychological Interventions; 4.5 Surgery for Breast Cancer
505 8 _a4.5.1 Surgery to Remove Breast Cancer4.5.1.1 Breast-Conserving Surgery (lumpectomy); 4.5.1.2 Mastectomy; 4.5.1.3 Simple (or total) Mastectomy; 4.5.1.4 Double Mastectomy; 4.5.1.5 Skin-Sparing Mastectomy; 4.5.1.6 Modified Radical Mastectomy; 4.5.1.7 Nipple-Sparing Mastectomy; 4.5.1.8 Radical mastectomy; 4.5.2 Lymph Node Surgery for Breast Cancer; 4.5.2.1 Biopsy of an Enlarged Lymph Node; 4.5.2.2 Types of Lymph Node Surgery; 4.5.2.3 Sentinel Lymph Node Biopsy (SLNB); 4.5.2.4 Axillary Lymph Node Dissection (ALND); 4.5.3 Reconstruction; 4.5.3.1 Types of Breast Reconstruction Procedures
520 3 _aCancer is the scandal magic event of Nature. Psycho-Oncogenetic is an insight for research, education, and translated cancer medicine that open a new window to patients, psychologists, surgeons, oncologists, haematologists, geneticists and scientists who are aimed to pave the ways towards an alternative management for cancer patients. Being cooperative, innovative, perceptive, and inspired are some essential characteristics for, participating in cancer translated research. Applicability of suggestive complementary insights including Pharmacogenomics (PG), Pharmacokinetics (PK), Pharmaco-Psycho-Somatic (PPS), Pharmaco-Psycho-Genomics (PPG), Pharmaco-Psycho-Kinetics (PPK), may facilitate the access of the Personalized Pharmaco-Therapy (PPT) as the reliable target-based strategy. So, by bridging Pharmacogenetics to Psycho-Genetics, the harmonized and multi- target-based insights would, gradually, facilitate to connect the initial station of cancer coach to the final station of cancer management, which is the appropriate individualized cancer therapy. In this regards, the global insight is required to be replaced by the personalized cascade management from A to Z. It was my task and aim to consider a comprehensive manner in editing of this book. This endeavor was relied on the authors and co-authors who have, greatly, contributed to this package which will, hopefully, spread the provided basic and applicable scientific, and clinical messages to the audiences who play roles in the cancer world. The contents of this book include 26 chapters including basic Science/Genetics, psychology and clinical aspects in different tumors. The contents of this package may inspire a profounder concern of coordinated strategy in cancer research and cancer management. Besides, it may also provide some clues to positioning of puzzles for innovating the target-based cancer therapy. Let's move towards planning an appropriate social life style with an individualized diagnosis and management for cancer patients. By considering the global sharing, triggering the burdens is the key aim in cancer.
650 7 _aCancer
_xGenetic aspects.
_2fast
_0(OCoLC)fst00845368
_9139308
_0comprobar BNE19900970859
700 1 _aMehdipour, Parvin.
_994288
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-64550-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aEBOOK, asignarmaterias, EBSPRINGER_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c96545
_d96545
_x1